Log in

Relevant bibliographies by topics / Microdosed oral contraceptives

Contents

Journal articles

Academic literature on the topic 'Microdosed oral contraceptives'

Author: Grafiati

Published: 5 June 2025

Last updated: 2 August 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Microdosed oral contraceptives.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Microdosed oral contraceptives"

1

Buralkina, N. A. "Correctness of use of microdosed combination oral contraceptives in young women." Gynecology 19, no. 4 (2017): 26–29. http://dx.doi.org/10.26442/2079-5696_19.4.26-29.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Pologoyko, Galina Petrovna. "Hormonal contraception in women with diffuse nontoxic goiter and autoimmune thyroiditis." Journal of obstetrics and women's diseases 62, no. 5 (2013): 45–51. http://dx.doi.org/10.17816/jowd62545-51.

Full text

Abstract:

The article considers the influence of combined oral contraceptives on size and function of thyroid gland in women of reproductive age. We examined 215 women, taking low dose and microdose combined oral contraceptives for 12 months as monotherapy or in combination with potassium iodide. The first group consisted of 75 women with diffuse nontoxic goiter, second – of 70 women with autoimmune thyroiditis. Control group consisted of 70 women without pathology of thyroid gland. Prior to therapy with combined contraceptives and after 12 months of treatment, we determined serum levels of free triiodo

APA, Harvard, Vancouver, ISO, and other styles

3

Oboskalova, Tat’iana A., Evgenii Yu Gluhov, and Irina I. Astryuhina. "Features of ambulatory and stationary treatment of patients with endometriosis." Gynecology 21, no. 6 (2020): 51–56. http://dx.doi.org/10.26442/20795696.2019.6.190757.

Full text

Abstract:

Background. Most common clinical manifestations of endometriosis (N80) include pelvic pain and infertility, while adenomyosis is associated with abnormal uterine bleeding. At present, approach to the treatment of endometriosis has been revised towards shifting surgery to the second-line therapy; medications are considered as the first-line therapy: gonadotropin releasing hormone agonists, progestogens, aromatase inhibitors. Aim. Comparison of clinical and anamnestic characteristics and therapeutic procedures in women who were treated on an outpatient basis and those who were hospitalized

APA, Harvard, Vancouver, ISO, and other styles

4

Khodjaeva, Zarina Alikhanovna, and Djuraevna Muratova Nigora. "Features of clinical and laboratory parameters of adenomyosis combined with endometrioid ovarian cysts." Journal of reproductive health and uro-nephrology research 3, no. 4 (2022): 4. https://doi.org/10.5281/zenodo.7420829.

Full text

Abstract:

The most common diseases among women of reproductive age include fibroids, adenomyosis and endometrioid ovarian cysts. The aim of the study was to determine the clinical and laboratory parameters of adenomyosis combined with endometrioid ovarian cysts in young women. We examined 80 women of reproductive age with adenomyosis and endometriosis of the ovaries. The average age of the examined patients was 25.4±0.14 years. All patients underwent hormonal, ultrasound and Doppler methods of examination. The results of the studies showed that 70% of the examined patients reported bleeding from

APA, Harvard, Vancouver, ISO, and other styles

5

Sokolova, T. M., K. Yu Makarov, T. V. Kiseleva, and A. V. Yakimova. "Non-contraceptive effects of microdose folate-containing oral contraceptive in patients of child bearing age." Medical Council, no. 13 (September 25, 2018): 46–49. http://dx.doi.org/10.21518/2079-701x-2018-13-46-49.

Full text

Abstract:

The article provides a summary of the evaluation of efficacy of folate-containing oral contraceptive (Yaz® plus) containing gestagen with antiandrogenic and antimineralocorticoid effect, which, neutralizes the symptoms of primary dysmenorrhea in addition to preventing unwanted pregnancies, and also has registered indications for the treatment of acne.

APA, Harvard, Vancouver, ISO, and other styles

6

Ovsyannikova, Tamara V., and Ilya A. Kulikov. "Hormonal contraception in women of reproductive age: endocrinological aspects." Gynecology 21, no. 1 (2019): 65–68. http://dx.doi.org/10.26442/20795696.2019.1.190285.

Full text

Abstract:

Relevance. Woman’s late reproductive age is a period of complex hormonal adjustment, a preparation for menopause onset. Despite a decline in a reproductive potential and accumulation of gynecological and extragenital diseases in this population a gynecologist has to deal with their contraception as well as a treatment of menstrual disorders and a prevention of hyperplastic processes in the genitals. A search for safe and reliable drugs to solve these problems is extremely important in women of late reproductive period. Aim. Based on date of modern clinical and scientific research a relevance o

APA, Harvard, Vancouver, ISO, and other styles

7

Karasjov, Vladimir Ye, V. T. Dolgikh, and O. V. Leonov. "Treatment of fertile age patients with benign breast tumors." Russian Journal of Oncology 20, no. 3 (2015): 12–16. http://dx.doi.org/10.17816/onco40148.

Full text

Abstract:

The article presents the results of the treatment of 85 fertile age women with breast fibroadenomas. They were operated either by partial mastectomy or by vacuum aspiration removal of fibroadenomas with En-Cor apparatus. The study evaluated therapeutic effect on the hormonal background of the women with breast fibroadenomas achieved by monophase microdose complex oral contraceptives (ethinyl estradiol at the dose of 20 pg) or by vacuum aspiration. The use of En-Cor apparatus was effective not only in total fibroadenoma removal, but also in excellent cosmetic results, reduction of the operation

APA, Harvard, Vancouver, ISO, and other styles

8

Nazarova, N., E. Mejevitinova, P. Abakarova, A. Akopian, and R. Sasunova. "P745 The efficiency and acceptability microdosed out of oral contraceptive at women of reproductive age." International Journal of Gynecology & Obstetrics 107 (October 2009): S625. http://dx.doi.org/10.1016/s0020-7292(09)62236-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Khachaturian, A. R., E. V. Misharina, and M. I. Yarmolinskaya. "Efficacy and safety of drospirenone-containing microdosage combined oral contraceptive use with starting contraception." Gynecology 20, no. 2 (2018): 9–13. http://dx.doi.org/10.26442/2079-5696_2018.2.9-13.

Full text

Abstract:

Androgen-dependent dermopathy, as well as premenstrual syndrome of varying severity in young women, can cause emotional depression, difficulties in social adaptation and even depressive disorders. The aim of the study was to study the safety and efficacy of using a combined oral contraceptive (COC) Dimia® containing 20 μg ethinyl estradiol and 3 mg drospirenone in young women, as well as its therapeutic effects in androgen-dependent dermopathy. Materials and methods. The study included 57 young women aged 23.1±2.2 years with signs of androgen-dependent dermopathy. The evaluation of the change

APA, Harvard, Vancouver, ISO, and other styles

10

Khashchenko, E. P., O. I. .Lisitsyna, and E. V. Uvarova. "Diagnosis and management of patients with hyperandrogenism in early reproductive age." Voprosy ginekologii, akušerstva i perinatologii 20, no. 5 (2021): 124–30. http://dx.doi.org/10.20953/1726-1678-2021-5-124-130.

Full text

Abstract:

Hyperandrogenism is characterized by the presence of clinical symptoms and / or biochemical parameters of high androgen levels. Dermopathy and particularly acne and hirsutism are regarded as the main clinical markers of hyperandrogenism. Cosmetic problems associated with hyperandrogenism are often the reason for young woman to seek medical attention. Body hair growth in atypical areas, acne and trophic skin changes have a significant effect on the emotional state, provoke a sense of imperfection and loss of attractiveness, and reduce the quality of life. Concomitant menstrual disorders (up to

APA, Harvard, Vancouver, ISO, and other styles

More sources

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!